![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/18 | (2006.01) |
G01N 33/564 | (2006.01) | ||
G01N 33/68 | (2006.01) |
(11) | Number of the document | 2542580 |
(13) | Kind of document | T |
(96) | European patent application number | 11708716.3 |
Date of filing the European patent application | 2011-03-04 | |
(97) | Date of publication of the European application | 2013-01-09 |
(45) | Date of publication and mention of the grant of the patent | 2021-08-04 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2011/001090 |
Date | 2011-03-04 |
(87) | Number | WO 2011/107291 |
Date | 2011-09-09 |
(30) | Number | Date | Country code |
349410 P | 2010-05-28 | US | |
310519 P | 2010-03-04 | US |
(72) |
FROSTEGARD, Johan , SE
|
(73) |
Athera Biotechnologies AB ,
Business Center
S:t Eriksgatan 117, 113 43 Stockholm,
SE
|
(54) | ANTIBODIES AGAINST PHOSPHORYLCHOLINE IN COMBINATION THERAPY WITH BIOLOGIC AGENTS |
ANTIBODIES AGAINST PHOSPHORYLCHOLINE IN COMBINATION THERAPY WITH BIOLOGIC AGENTS |